Related Experiment Video

Updated: Jan 5, 2026

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.2K

Development of a model of ischemic heart disease using cardiomyocytes differentiated from human induced pluripotent

Heng Wei1, Chen Wang2, Rui Guo3

  • 1Department of Cardiovascular Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan; Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.

Biochemical and Biophysical Research Communications
|October 19, 2019
PubMed

Insights

Researchers developed a human-based model for ischemic heart disease using human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs). This model accurately mimics human heart conditions, offering a better platform for studying heart disease than animal models.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Research
  • Ischemic Heart Disease Modeling

Background:

  • Ischemic heart disease is a leading global cause of mortality.
  • Current research often relies on animal models, which have significant physiological differences from the human heart.
  • Developing human-specific models is crucial for understanding and treating heart disease.

Purpose of the Study:

  • To create a novel in vitro model of ischemic heart disease using human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs).
  • To optimize ischemic conditions for this human cell model.
  • To validate the model's relevance to human ischemic heart disease pathophysiology.

Main Methods:

  • Differentiation of human induced pluripotent stem cells into cardiomyocytes (hiPS-CMs).
  • Optimization of ischemic conditions: low oxygen (2%), glucose deprivation (0 mg/ml), and serum absence (0% fetal bovine serum).
  • Assessment of cellular damage using propidium iodide staining and evaluation of cellular viability and contractility.

Main Results:

  • Optimized ischemic conditions significantly increased membrane damage (propidium iodide uptake) and decreased hiPS-CM viability.
  • Cellular contractility was markedly reduced under these ischemic conditions.
  • Increased mRNA expression of IL-8 was observed, mirroring in vivo responses.

Conclusions:

  • The developed hiPS-CM-based model effectively replicates key features of human ischemic heart disease.
  • This model provides a valuable platform for studying disease mechanisms and testing potential therapies.
  • It overcomes limitations associated with traditional animal models in cardiovascular research.

Keywords:
CardiomyocytesHuman induced pluripotent stem cellsIschemic heart diseaseMyocardial infarction

More Related Videos

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells13:18

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Published on: June 28, 2013

22.0K
Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells05:38

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

4.6K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K